Studies on the conformity of hibiscus sabdariffa l. samples from turkish market to european pharmacopeia

Fabad Journal of Pharmaceutical Sciences

Volumn 36, Issue 1, 2011, Pages 25-32

  Özdogan, Fidan Pesen ^a   Orhan, Nilüfer ^a   Ergun, Fatma ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

European Pharmacopeia; Hibiscus sabdariffa L.; Malvaceae

Indexed keywords

ANTHOCYANIN; DISULFINE BLUE; HIBISCUS SABDARIFFA EXTRACT; PHENOL; PROTOCATECHUIC ACID; QUINALDINE;

ANTIOXIDANT ACTIVITY; ARTICLE; ASH; CONTROLLED STUDY; EGYPT; FOREIGN BODY; HIBISCUS SABDARIFFA; MEDICAL LITERATURE; MICROSCOPY; NONHUMAN; PHYTOCHEMISTRY; TURKEY (REPUBLIC);

EID: 84876248841     PISSN: 13004182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ali BH, Wabel NA, Blunden G. Phytochemical, pharmacological and toxicological aspects of Hibiscus sabdariffa L.:A Review. Phytother Res 19: 369-375, 2005.
2. Mahadevan N, Kamboj S, Kamboj P. Hibiscus sabdariffa Linn.-An overview. NPR 8 (1): 77-83, 2009.
3. The Complete German Commission E Monographs. Therapeutic Guide to Herbal Medicines. Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW, Rister RS, eds. Klein S, Rister RS, trans. Austin, Texas: American Botanical Council; Boston: Integrative Medicine Communication; 1998. p. 336.
4. Herrera-Arellano A, Miranda-Sánchez J, Ávila-Castro P, Herrera-Álvarez S, Enrique Jiménez-Ferrer J, Zamilpa A, Román-Ramos R, Ponce-Monter H, Tortoriello J. Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, Lisinopril-controlled clinical trial. Planta Med 73: 6-12, 2007.
5. Vasudeva N, Sharma SK. Biologically active compounds from the genus Hibiscus. Pharm Biol 46: 145-153, 2008.
6. Gangrade H, Mishra SH, Kaushal R. Antimicrobial activity of oil and unsaponifiable matter of red roselle. Indian Drugs 16: 147-148, 1979.
7. Wahabi HA, Alansary LA, Al-Sabban AH, Glasziuo, P. The effectiveness of Hibiscus sabdariffa in the treatment of hypertension: A systematic review. Phytomedicine 17: 83-86, 2010.
8. Dafallah AA, Al-Mustafa Z. Investigation of the inflammatory activity of Acacia nilotica and Hibiscus sabdariffa. Am J Chinese Med 24: 263-269, 1996.
9. Hirunpanich V, Utaipat A, Morales NP, Bunyapraphatasara N, Sato H, Herunsalee A, Suthisisang C. Antioxidant effects of aqueous extracts of dries calyx of Hibiscus sabdariffa Linn., (roselle) in vitro using rat low-density lpoprotein (LDL). Biol Pharm Bull 28: 481-484, 2005.
10. Ali MB, Salih WM, Mohamed AH, Homeida AM. Investigation of the antispasmodic potential of Hibiscus sabdariffa calyces. J Ethnopharmacology 31: 249-256, 1991.
11. Tseng TH, Kao TW, Chu CY, Chou FP, Lin WL, Wang CJ. Induction of apoptosis by Hibiscus protocatechuic acid in human leukemia cells via reduction of retinoblastoma (RB) phosphorylation and Bcl-2 expression. Biochem Pharmacol 60: 307-315, 1998.
12. Hansawasdi C, Kawabata J, Kasai T. Alpha amylase inhibitors from roselle (H. sabdariffa Linn.) tea. Biosci Biotechnol Biochem 64: 1041-1043, 2000.
13. European Pharmacopeia 7.0, The Directorate for the Quality of Medicines of the Council of Europe (EDQM). Strasbourg: 2008. p.1226-1227.
14. Zongo C, Sacadogo L, Ouattara IHN, Ouattara AS, Barro N, Koudou J, Traore AS. Polyphenols content, antioxidant and antimicrobial activities of Ampelocissus grantii (Baker) Planch. (Vitaceae): A Medicinal Plant from Burkina Faso. Int J Pharmacol 6 (6): 880-887, 2010.
15. Jung HA, Jin SE, Choi RJ, Manh HT, Kim YS, Min BS, Son YK, Ahn BR, Kim BW, Sohn HS, Choi JS. Anti-tumorigenic activity of Sophoflavascenol against Lewis lung carcinoma in vitro and in vivo. Arch Pharm Res 34 (12): 2087-2099, 2011.
16. Wagner H, Bladt S. Plant Drug Analysis. Second Edition. Berlin: Springer; 1996. p. 281-287.
17. Gonzales-Stuart A. Multifaceted therapeutic value of roselle (Hibiscus sabdariffa L.-Malvaceae). In Watson RR, et al. (eds.) Nutrients, Dietary Supplements, and Nutraceuticals: Cost Analysis Versus Clinical Benefits, Nutrition and Health. LLC: Springer; 2011. p. 215-226.